Degenerative Disc Disease

The US Food and Drug Administration has approved Interventional Spine’s Opticage expandable intervertebral body fusion device, used for the treatment of degenerative disc disease (DDD).

The Opticage expandable interbody is an integral part of the company’s PerX360 System, which enables surgeons to perform a complete 360° percutaneous lumbar interbody fusion through a two 15mm incisions for the treatment of lumbar discogenic pain.

Professor David Greenwald of the Flagler Brain and Spine Institute in St Augustine, Florida, US, said that using Opticage expandable interbody, the channel for insertion is reduced and will help minimise tissue trauma and decrease the patient overall recovery times. “This is a significant milestone in the progression of making lumbar spinal fusion surgeries less invasive to patients.To my knowledge, no other interbody fusion cage in the market has the expansion capabilities of the Opticage,” Greenwald added.

Interventional Spine CEO Walter Cuevas said they look forward to partnering with surgeons in the US to make the technology available to them in a manner that will benefit their patients.

Neurosurgery and Spine, Milwaukee, Wisconsin, US professor Cully White said the approval provides Interventional Spine with a unique technology, capable of transforming how lumbar spine fusion is performed, experiencing less pain, shorter hospital stays and better outcomes overall.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Based in California, US, Interventional Spine designs, develops and markets patented implantable devices for the spine that can be deployed via percutaneous techniques.

The Opticage expandable intervertebral body fusion device is an addition to the company’s product portfolio including Perpos PLS system, Perpos percutaneous cervical system, PDS system and Renew Allograft. The Perpos percutaneous cervical system comprises a 3.8mm CS facet compression device which is indicated for the treatment of spondylolisthesis, spondylolysis and DDD. The Perpos PLS system is a complete set of instruments engineered for percutaneous implantation of the Bone-Lok implant that enables single or multilevel bilateral fixation without rods and screws.

Image: Micrograph of a fragment of a resected degenerative vertebral disc, showing degenerative fibrocartilage and clusters of chondrocytes. Photo: Nephron.